149 related articles for article (PubMed ID: 31822972)
1. Usefulness of imaging findings in predicting tumor-infiltrating lymphocytes in patients with breast cancer.
Çelebi F; Agacayak F; Ozturk A; Ilgun S; Ucuncu M; Iyigun ZE; Ordu Ç; Pilanci KN; Alco G; Gultekin S; Cindil E; Soybir G; Aktepe F; Özmen V
Eur Radiol; 2020 Apr; 30(4):2049-2057. PubMed ID: 31822972
[TBL] [Abstract][Full Text] [Related]
2. BI-RADS Ultrasound Lexicon Descriptors and Stromal Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer.
Candelaria RP; Spak DA; Rauch GM; Huo L; Bassett RL; Santiago L; Scoggins ME; Guirguis MS; Patel MM; Whitman GJ; Moulder SL; Thompson AM; Ravenberg EE; White JB; Abuhadra NK; Valero V; Litton J; Adrada BE; Yang WT
Acad Radiol; 2022 Jan; 29 Suppl 1(Suppl 1):S35-S41. PubMed ID: 34272161
[TBL] [Abstract][Full Text] [Related]
3. Correlation between apparent diffusion coefficient of magnetic resonance imaging and tumor-infiltrating lymphocytes in breast cancer.
Fogante M; Tagliati C; De Lisa M; Berardi R; Giuseppetti GM; Giovagnoni A
Radiol Med; 2019 Jul; 124(7):581-587. PubMed ID: 30806920
[TBL] [Abstract][Full Text] [Related]
4. Evaluating Tumor-Infiltrating Lymphocytes in Breast Cancer: The Role of Conventional Ultrasound and Contrast-Enhanced Ultrasound.
Jia Y; Zhu Y; Li T; Song X; Duan Y; Yang D; Nie F
J Ultrasound Med; 2023 Feb; 42(3):623-634. PubMed ID: 35866231
[TBL] [Abstract][Full Text] [Related]
5. Novel tumor-infiltrating lymphocytes ultrasonography score based on ultrasonic tissue findings predicts tumor-infiltrating lymphocytes in breast cancer.
Fukui K; Masumoto N; Shiroma N; Kanou A; Sasada S; Emi A; Kadoya T; Yokozaki M; Arihiro K; Okada M
Breast Cancer; 2019 Sep; 26(5):573-580. PubMed ID: 30868399
[TBL] [Abstract][Full Text] [Related]
6. Radiological Features for Predicting the Status of CD8-Positive Lymphocytes in HER2 Positive Breast Cancer.
Fan Y; Li X; Zhong P; Guo H; Han D; Tian W; Fang J
Balkan Med J; 2024 May; 41(3):213-221. PubMed ID: 38700366
[TBL] [Abstract][Full Text] [Related]
7. The tumor-infiltrating lymphocyte ultrasonography score can provide a diagnostic prediction of lymphocyte-predominant breast cancer preoperatively.
Kanou A; Masumoto N; Fukui K; Yokozaki M; Sasada S; Emi A; Kadoya T; Arihiro K; Okada M
J Med Ultrason (2001); 2022 Oct; 49(4):709-717. PubMed ID: 36002708
[TBL] [Abstract][Full Text] [Related]
8. HER2-Positive Breast Cancer: Association of MRI and Clinicopathologic Features With Tumor-Infiltrating Lymphocytes.
Lee HJ; Lee JE; Jeong WG; Ki SY; Park MH; Lee JS; Nah YK; Lim HS
AJR Am J Roentgenol; 2022 Feb; 218(2):258-269. PubMed ID: 34431365
[No Abstract] [Full Text] [Related]
9. Correlation Between MRI and the Level of Tumor-Infiltrating Lymphocytes in Patients With Triple-Negative Breast Cancer.
Ku YJ; Kim HH; Cha JH; Shin HJ; Baek SH; Lee HJ; Gong G
AJR Am J Roentgenol; 2016 Nov; 207(5):1146-1151. PubMed ID: 27556407
[TBL] [Abstract][Full Text] [Related]
10. A simple and convenient model combining multiparametric MRI and clinical features to predict tumour-infiltrating lymphocytes in breast cancer.
Chen S; Sui Y; Ding S; Chen C; Liu C; Zhong Z; Liang Y; Kong Q; Tang W; Guo Y
Clin Radiol; 2023 Dec; 78(12):e1065-e1074. PubMed ID: 37813758
[TBL] [Abstract][Full Text] [Related]
11. Magnetic resonance imaging and molecular features associated with tumor-infiltrating lymphocytes in breast cancer.
Wu J; Li X; Teng X; Rubin DL; Napel S; Daniel BL; Li R
Breast Cancer Res; 2018 Sep; 20(1):101. PubMed ID: 30176944
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Tumor infiltrating lymphocytes in breast carcinoma and their correlation with molecular subtypes, tumor grade and stage.
Pujani M; Jain H; Chauhan V; Agarwal C; Singh K; Singh M
Breast Dis; 2020; 39(2):61-69. PubMed ID: 32310155
[TBL] [Abstract][Full Text] [Related]
13. Body Mass Index and Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer.
Floris G; Richard F; Hamy AS; Jongen L; Wildiers H; Ardui J; Punie K; Smeets A; Berteloot P; Vergote I; De Croze D; Meseure D; Salomon A; Laé M; Reyal F; Biganzoli E; Neven P; Desmedt C
J Natl Cancer Inst; 2021 Feb; 113(2):146-153. PubMed ID: 33152071
[TBL] [Abstract][Full Text] [Related]
14. Role of diffusion-weighted MRI: predicting axillary lymph node metastases in breast cancer.
Chung J; Youk JH; Kim JA; Gweon HM; Kim EK; Ryu YH; Son EJ
Acta Radiol; 2014 Oct; 55(8):909-16. PubMed ID: 24234236
[TBL] [Abstract][Full Text] [Related]
15. Prediction of Treatment Response to Neoadjuvant Chemotherapy in Breast Cancer by Subtype Using Tumor-infiltrating Lymphocytes.
Asano Y; Kashiwagi S; Goto W; Takada K; Takahashi K; Hatano T; Takashima T; Tomita S; Motomura H; Ohsawa M; Hirakawa K; Ohira M
Anticancer Res; 2018 Apr; 38(4):2311-2321. PubMed ID: 29599354
[TBL] [Abstract][Full Text] [Related]
16. Correlation between
Murakami W; Tozaki M; Sasaki M; Hida AI; Ohi Y; Kubota K; Sagara Y
Eur J Radiol; 2020 Feb; 123():108773. PubMed ID: 31918248
[TBL] [Abstract][Full Text] [Related]
17. The Role of Stromal Tumour Infiltrating Lymphocytes (sTIL) Intensity and Programmed Death Ligand 1 () Expression in Breast Cancer Response to Neoadjuvant Therapy in Cipto Mangunkusumo Hospital (CMH), Indonesia.
Rustamadji P; Felicia D; Wuyung PE; Hellyanti T
Asian Pac J Cancer Prev; 2023 Oct; 24(10):3459-3465. PubMed ID: 37898851
[TBL] [Abstract][Full Text] [Related]
18. Tumour Infiltrating Lymphocytes (TILs) and immune composition in breast cancer patients from Kenya: Spatial distributions and associations with risk factors and tumour characteristics.
Sayed S; Koka H; Abubakar M; Gardner K; Salgado R; Moloo Z; Caban-Ureña AB; Rosen D; Castro P; Saleh M; Shaikh AJ; Shah J; Figueroa J; Makokha F; Ha HK; Wang Z; Magangane P; Naidoo R; Ngundo V; Yang XR; Govender D
Breast Cancer Res Treat; 2023 Jun; 199(2):401-413. PubMed ID: 37010652
[TBL] [Abstract][Full Text] [Related]
19. Predicting the level of tumor-infiltrating lymphocytes in patients with triple-negative breast cancer: Usefulness of breast MRI computer-aided detection and diagnosis.
Ku YJ; Kim HH; Cha JH; Shin HJ; Chae EY; Choi WJ; Lee HJ; Gong G
J Magn Reson Imaging; 2018 Mar; 47(3):760-766. PubMed ID: 28675570
[TBL] [Abstract][Full Text] [Related]
20. Impact of stromal tumor-infiltrating lymphocytes (sTILs) on response to neoadjuvant chemotherapy in triple-negative early breast cancer in the WSG-ADAPT TN trial.
Kolberg-Liedtke C; Feuerhake F; Garke M; Christgen M; Kates R; Grischke EM; Forstbauer H; Braun M; Warm M; Hackmann J; Uleer C; Aktas B; Schumacher C; Kuemmel S; Wuerstlein R; Graeser M; Nitz U; Kreipe H; Gluz O; Harbeck N
Breast Cancer Res; 2022 Sep; 24(1):58. PubMed ID: 36056374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
